Itraconazole Pellets Manufacturer: Improving the Delivery of a Poorly Soluble Antifungal

About Itraconazole

Itraconazole belongs to the triazole class of antifungals. It works by interfering with the formation of the fungal cell membrane. Its oral absorption depends heavily on formulation, because the drug is a weak base with very low solubility, especially at neutral pH.

The Bioavailability Challenge

Poor Solubility and Food/Acid Effects

Poor Solubility: Itraconazole dissolves only in acidic conditions and very poorly at intestinal pH. If it is released in a crystalline form, absorption can be low and variable.

Food and Acid Effects: Absorption from conventional capsules is influenced by food and gastric acidity, so formulators look for ways to reduce this variability.

How Pellet Technology Helps

Amorphous Solid Dispersions on Pellets

Amorphous Solid Dispersions: A common approach is to dissolve itraconazole with a hydrophilic polymer, such as a cellulose ether, and spray it onto inert beads. The drug dries in an amorphous, molecularly dispersed state in the polymer layer, which dissolves more readily than the crystalline drug.

Uniform Distribution & Capsule Filling: Multiple small pellets spread across the gastrointestinal tract, increasing contact with the absorption surface and supporting more consistent performance. Free-flowing pellets can also be filled accurately into hard capsules.

Typical Manufacturing Process

Solution Preparation, Layering & Solvent Recovery

Preparation of the Coating Solution: Itraconazole and the polymer are dissolved in a suitable solvent system. Control of solvent selection, concentration and viscosity is essential.

Layering on Sugar Spheres: The solution is sprayed onto inert beads in a fluid bed processor. Drying must be controlled to achieve the desired physical state of the drug and to remove solvent.

Seal Coating and Residual Solvent Control: A protective layer improves handling, prevents sticking and can influence release. Because organic solvents are often used, rigorous drying, solvent recovery and residual solvent testing are central to quality and safety.

Critical Quality Attributes

Challenges to Anticipate & Manufacturer Selection

Key Challenges & Selection Criteria

Challenges to Anticipate: Recrystallisation of the drug during storage, residual solvent limits, sticking and agglomeration during layering, scale-up from development to production batches, and uniformity of the drug layer on each pellet.

Selecting an Itraconazole Pellets Manufacturer: Choose a manufacturer familiar with solid dispersion technology and fluid bed layering of poorly soluble drugs. Facilities using flammable solvents must have appropriate safety systems, recovery and environmental controls.

Analytical & Documentation: Methods to detect crystallinity, measure dissolution and quantify impurities are critical for demonstrating consistent quality. Stability studies should confirm that the drug remains in the intended physical form throughout shelf life.

Why Choose Credo Life Sciences?

Credo Life Sciences focuses on pharmaceutical pellets and granules for formulation companies that need consistent quality, dependable supply and clear technical communication. We understand that a multiparticulate ingredient is only as good as its reproducibility from batch to batch, so our approach centres on controlled processes, thorough documentation and responsive support for your development and commercial needs. We work as a long-term partner to our customers, not just a vendor.